{
event: "article_read",
name: `What challenges do clinicians face in monitoring in disease progrission and response to therapy?`,
author: ``,
tags: `Pompe`,
publication_date: ``,
interaction_type: "content"
}
Read article
Read article
Read article
What challenges do clinicians face in monitoring in disease progrission and response to therapy?
Related articles
How has avalglucosidase alfa impacted the treatment paradigm for both infantile-onset and late-onset Pompe disease in your experience?
Have you observed any significant differences in treatment outcomes between these two therapies in your local practice?
What challenges do clinicians face in monitoring in disease progrission and response to therapy?
MAT-KW-2600384-V1-Jul-26